ATOS · Atossa Therapeutics, Inc. · Exempt Offerings
$1.65
-0.10 (-5.71%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2023 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$15.92M
Shares
9.98M
Volume · Nov 20
48.93K
Avg daily vol (3M)
67.59K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1488039
CUSIP
04962H704
13F (30d)
61 filings
35 filers
Visit website
Investor relations